|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 3.890 USD | -1.77% |
|
-21.57% | - |
| 09-20 | Conexeu Sciences Inc.(NasdaqCM:CNXU) added to S&P TMI Index | CI |
| 09-14 | Conexeu Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2026 | CI |
Company Valuation: Conexeu Sciences Inc.
Data adjusted to current consolidation scope
| Fiscal Period: October | 2026 | 2027 | 2028 |
|---|---|---|---|
| Market Cap 1 | 109.7 | - | - |
| Change | - | - | - |
| Enterprise Value (EV) | 109.7 | 109.7 | 109.7 |
| Change | - | 0% | 0% |
| P/E | -9.73x | -7.34x | 3.81x |
| PBR | - | - | - |
| PEG | -0.3x | -0.2x | -0x |
| Capitalization / Revenue | - | - | 0.78x |
| EV / Revenue | - | - | 0.78x |
| EV / EBITDA | - | - | - |
| EV / EBIT | -11.4x | -7.42x | 2.71x |
| EV / FCF | - | - | - |
| FCF Yield | - | - | - |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | -0.4 | -0.53 | 1.02 |
| Distribution rate | - | - | - |
| Net sales 1 | - | - | 140.2 |
| EBITDA | - | - | - |
| EBIT 1 | -9.592 | -14.78 | 40.51 |
| Net income 1 | -9.512 | -14.78 | 37.92 |
| Net Debt | - | - | - |
| Reference price 2 | 3.890 | 3.890 | 3.890 |
| Nbr of stocks (in thousands) | 28,207 | - | - |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CNXU Stock
- Valuation Conexeu Sciences Inc.
Select your edition
All financial news and data tailored to specific country editions
